OPKO Health to Participate at Three Investment Conferences in December
Nov 30, 2016 13:00 pm UTC| Business
MIAMI, Nov. 30, 2016 -- OPKO Health, Inc. (NASDAQ:OPK), announces that its senior management team will host one-on-one investor meetings with institutional investors participating at the following investor conferences...
Diabetes in the United States: Gallup and Healthways Rank 50 States and 190 Communities
Nov 30, 2016 13:00 pm UTC| Business
WASHINGTON NASHVILLE, Tenn., Nov. 30, 2016 -- World-leading analytics and advice firm Gallup, and global well-being improvement leader,Healthways, a Sharecare company, have released new research – part of the...
Nov 30, 2016 13:00 pm UTC| Business
DALLAS, Nov. 30, 2016 -- McElhenny Sheffield Capital Management(MSCM) is pleased to announce the execution of a Succession Plan Agreement with Inspire Capital Management as part of Inspire Capital’s continuing...
Nov 30, 2016 13:00 pm UTC| Business
LAWRENCEVILLE, N.J., Nov. 30, 2016 -- Celsion Corporation(NASDAQ:CLSN) today announced that following a review of data from its multinational, randomized pivotal Phase III clinical study of ThermoDox® in combination...
Nov 30, 2016 13:00 pm UTC| Business
ROMAINVILLE, France, Nov. 30, 2016 -- BIOPHYTIS (Alternext Paris:ALBPS), a biotechnology company specialized in the development of drug candidates to treat aging diseases, announces the successful completion of its...
Viracta acquires Phase 2 epigenetic drug candidate from Chroma Therapeutics
Nov 30, 2016 13:00 pm UTC| Business
SAN DIEGO and LONDON, Nov. 30, 2016 -- Viracta Therapeutics, Inc. announced completion of its acquisition of drug development candidate, VRx-3996, from Chroma Therapeutics, Ltd. Viracta plans to advance VRx-3996...
Nov 30, 2016 13:00 pm UTC| Business
PARIS and TOULOUSE, France, Nov. 30, 2016 -- Genticel (Euronext Paris Brussels: FR00011790542 – GTCL), a clinical-stage biotechnology company and developer of innovative immunotherapies, today announced that a...